tiprankstipranks
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market
Want to see NDRA full AI Analyst Report?

ENDRA Life Sciences (NDRA) Financial Statements

856 Followers

ENDRA Life Sciences Financial Overview

ENDRA Life Sciences's market cap is currently $6.04M. The company's EPS TTM is $-3.26; its P/E ratio is -0.28; ENDRA Life Sciences is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ -275.45K$ -234.26K$ -224.41K
Operating Income$ -5.76M$ -10.82M$ -10.52M$ -13.16M$ -11.50M
EBITDA$ -5.61M$ -10.77M$ -9.78M$ -12.94M$ -11.01M
Net Income$ -7.03M$ -11.51M$ -10.06M$ -13.18M$ -11.23M
Balance Sheet
Cash & Short-Term Investments$ 762.37K$ 3.23M$ 2.83M$ 4.89M$ 9.46M
Total Assets$ 3.85M$ 4.45M$ 6.75M$ 9.27M$ 12.87M
Total Debt$ 492.35K$ 584.42K$ 394.40K$ 546.63K$ 796.09K
Net Debt$ -270.01K$ -2.65M$ -2.44M$ -4.34M$ -8.67M
Total Liabilities$ 1.59M$ 1.89M$ 1.10M$ 2.07M$ 2.09M
Stockholders' Equity$ 2.26M$ 2.56M$ 5.66M$ 7.20M$ 10.78M
Cash Flow
Free Cash Flow$ -5.20M$ -7.42M$ -9.58M$ -12.97M$ -11.17M
Operating Cash Flow$ -5.18M$ -7.40M$ -9.55M$ -12.77M$ -11.12M
Investing Cash Flow$ -3.02M$ -12.80K$ -24.72K$ -202.58K$ -45.00K
Financing Cash Flow$ 5.73M$ 7.81M$ 7.52M$ 8.40M$ 13.40M
Currency in USD

ENDRA Life Sciences Earnings and Revenue History

ENDRA Life Sciences Debt to Assets

ENDRA Life Sciences Cash Flow

ENDRA Life Sciences Forecast EPS vs Actual EPS